US$ 22.36
glp-1-ra How should GLP-1 receptor agonists be managed in the perioperative period? Glucagon-like peptide-1 receptor: mechanisms and
Description
Large observational studies have found that GLP-1 receptor agonists are associated with a lower risk of non-candida urinary tract infections compared to SGLT2 inhibitors, with a hazard ratio of 0.91 or lower and statistical significance below 0.001

Helping people understand what to expect will be key to building confidence and long-term use

The fund is quite niche, so it has a modest asset base of some $52 million and relatively low trading volumes

AlBreiki M, AlMaqbali M, AlRisi K, AlSinawi H, Al Balushi M, Al Zakwani W

Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes

A significant reduction in DBP compared to placebo was observed only for exenatide BID (1.08 mmHg [95% CI 1.78 to 0.33])
